Nationwide epidemiological characteristics of chronic fatigue syndrome in South Korea.
Lim, Eun-Jin, Lee, Jin-Seok, Lee, Eun-Jung et al. · Journal of translational medicine · 2021 · DOI
Quick Summary
This study looked at medical records from South Korea between 2010 and 2020 to understand how many people have ME/CFS and who gets diagnosed with it. Researchers found that about 45 out of every 100,000 people are newly diagnosed each year, and roughly 58 out of every 100,000 people have the condition overall. The number of diagnoses roughly doubled over the 10-year period, with women being about 1.5 times more likely to be diagnosed than men, and cases increasing with age.
Why It Matters
This is the first large-scale, population-level study documenting ME/CFS epidemiology in South Korea, providing evidence that the condition is increasingly recognized and diagnosed. The rising incidence and prevalence rates challenge the notion that ME/CFS is rare or declining, supporting the need for greater clinical awareness and healthcare resource allocation. These real-world epidemiological data strengthen the case for ME/CFS as a legitimate public health concern requiring improved diagnostic and care pathways.
Observed Findings
Annual mean incidence: 44.71 ± 6.10 cases per 100,000 individuals (95% CI: 40.57–48.76)
Incidence and prevalence each increased approximately 1.5–1.9 fold between 2010 and 2020
Female-to-male predominance ratio of approximately 1.5:1
Prevalence increased with advancing age
Inferred Conclusions
ME/CFS is a recognizable and measurable public health condition in South Korea with quantifiable epidemiological rates
CFS diagnosis and awareness among physicians increased substantially during the 2010–2020 period
CFS disproportionately affects women and older age groups
The rising trend suggests either increasing incidence or improved recognition of the condition by healthcare providers
Remaining Questions
Does the observed increase in diagnosed cases reflect true rising disease incidence, improved physician awareness and diagnostic accuracy, or changes in diagnostic coding practices?
What are the underlying causes of the apparent female predominance and age-related increase in prevalence?
What This Study Does Not Prove
This study does not establish what causes ME/CFS, why it is increasing, or whether the rise reflects true disease incidence changes versus improved physician recognition and diagnostic accuracy. It cannot determine whether diagnostic criteria or coding practices changed over the decade, which could account for some of the apparent increase. Claims data also cannot distinguish disease severity, track individual patient outcomes, or identify risk factors for developing ME/CFS.
Tags
Symptom:Fatigue
Method Flag:PEM Not DefinedWeak Case DefinitionExploratory Only